September 29, 2014
We speak to Derek Gatherer from the Division of Biomedical and Life Sciences at Lancaster University, UK, to get an overview of the Ebola outbreak. Gatherer is a bioinformaticist whose field of application is the evolution of viruses.
1 min read
September 23, 2014
Manufacturing stem cells for use in research is one thing; doing it on a commercial scale – with all the associated costs and scale-up issues – is an entirely different ballgame. Here, I look at the challenges ahead and the groups rising to meet them.
1 min read
September 23, 2014
Antibiotics were once hailed as wonder drugs in the war against infection, but now it looks like bacteria might have the upper hand. How can we turn the tide?
1 min read
September 23, 2014
An FDA Warning Letter can be a real wake up call. How can you address the root of the problem to protect against future violations?
1 min read
September 22, 2014
Sitting Down With… Wim Leereveld, founder and CEO of the Access to Medicine Foundation
1 min read
September 22, 2014
In today’s competitive market, OPEX is – or at least should be – a priority for all pharmaceutical manufacturers. Looking back on just a decade of progress, what have we learned and where do we go next?
1 min read
September 22, 2014
Today’s pharmaceutical manufacturing operations capture huge amounts of data. Unfortunately, in many cases the data pass by without actual context. How do we obtain the digital “Holy Grail” – a fully mapped process that facilitates decision-making using data we trust?
1 min read
September 22, 2014
Times are a changing. The rise of biopharmaceuticals has resulted in the need for cheaper, faster manufacture without a subsequent sacrifice in safety. Here, I offer my vision of how the manufacturing facilities of the future will combine the technologies of today and tomorrow.
1 min read
September 22, 2014
The World Health Organization has compiled a list of 17 tropical diseases that deserve higher priority. Is the pharmaceutical industry solely to blame for a lack of progress?
1 min read
September 22, 2014
Is there a ‘safe’ hold time for sterilized items? And, if so, how can those hold times be reliably validated?
1 min read
September 22, 2014
After years of intense criticism, the European Parliament has adopted a new regulation for clinical trials that will replace the current EU Clinical Trials Directive by mid-2016. But is it enough to reverse a decade of decline in European clinical research?
1 min read
September 19, 2014
Lilly and Sanofi go head-to-head on a diabetes drug. Meanwhile, Hospira sues the FDA over a new generic approval.
1 min read
September 19, 2014
Could tackling bottlenecks in early-stage R&D provide a faster route to the clinic?
1 min read
September 19, 2014
European Commission (EC) plans to transfer governance of the medicines dossier from health to enterprise has upset public health NGOs.
1 min read
September 19, 2014
In October, CPhI Worldwide 2014, along with ICSE, P-MEC and InnoPack, comes to the City of Light - Paris. Here, we bring you some key facts and figures about the event.
1 min read
September 19, 2014
New vaccines, experimental treatments for patients, and cash donations make their mark on the Ebola outbreak.
1 min read
September 9, 2014
Economic pressures, new technology and the rise of biologics are all having a huge impact on the pharmaceutical industry. What will the next 10 years hold for drug and biologics manufacture? To answer that question, Gert Moelgaard reviews the factors driving big change in manufacturing and Guillaume Plane takes us on a tour of the facility of the near future.
1 min read
September 4, 2014
If you work in the development or manufacture of drugs and biologics – this is your magazine.
1 min read
